Stay updated on Reirradiation With Pembrolizumab in Head-and-Neck Clinical Trial

Sign up to get notified when there's something new on the Reirradiation With Pembrolizumab in Head-and-Neck Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Reirradiation With Pembrolizumab in Head-and-Neck Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4; no changes to study details or core page content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:15:24.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Added a Locations section with Maryland and Pennsylvania entries and updated the page revision to v3.3.3. Removed the Maryland Locations and Pennsylvania Locations sections and the HHS Vulnerability Disclosure link, replacing revision v3.3.2 with v3.3.3.
    Difference
    0.3%
    Check dated 2025-12-23T12:32:30.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Footer revision updated to v3.3.2, replacing the previous v3.3.1.
    Difference
    0.1%
    Check dated 2025-12-01T17:52:05.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Revision: v3.3.1 replaces the previous v3.2.0 on the page. No substantive study details or functionality changes are indicated.
    Difference
    0.1%
    Check dated 2025-11-24T14:47:37.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Deleted the government funding lapse notice that was previously displayed on the page; it had directed users to cc.nih.gov and opm.gov for operating status updates.
    Difference
    0.4%
    Check dated 2025-11-17T06:55:10.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    Results for NCT02289209 were posted on ClinicalTrials.gov on 2025-03-06, including updated outcome measures and data tables.
    Difference
    0.4%
    Check dated 2025-11-03T01:19:47.000Z thumbnail image

Stay in the know with updates to Reirradiation With Pembrolizumab in Head-and-Neck Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Reirradiation With Pembrolizumab in Head-and-Neck Clinical Trial page.